Two specialists are impressed by the preliminary findings of a randomized trial in newly diagnosed patients, but another is ...

Q: I recently brought myself to the hospital because my electrocardiogram (EKG) result showed “possible ischemia.” I went to ...

Amjevita is a prescription drug used to treat certain inflammatory conditions. Learn about the common, mild, and serious side ...

EPIX READ THE FULL EPIX RESEARCH REPORT Business Update Masofaniten plus Enzalutamide Results in Increased rPFS On September ...

Primary central nervous system (CNS) vasculitis is a rare, frequently misdiagnosed condition that affects the brain and ...

Objectives Cardiovascular disease is a leading cause of mortality in systemic lupus erythematosus (SLE). Frailty has been ...

Adalimumab was superior to cyclosporine in preventing uveitis relapse in patients with severe Behçet disease already on ...

During a Case-Based Roundtable® event, Christopher Maisel, MD, discussed the data behind loncastuximab and whether ...

The limitations of currently available therapies for immune thrombocytopenia (ITP) mean that long-term responses are ...

Detailed results from the TROPION-Lung01 Phase III trial showed a clinically meaningful trend toward improving overall survival (OS) with datopotamab ...

In addition, her serum creatinine was elevated at 3.4 mg/dL. Chest imaging demonstrated bilateral patchy ... She was started on pulse steroids, which was later transitioned to prednisone oral tapering ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced long-term overall survival (OS) data ...